Heribert Juergens

5.5k total citations · 1 hit paper
60 papers, 3.3k citations indexed

About

Heribert Juergens is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Heribert Juergens has authored 60 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pulmonary and Respiratory Medicine, 22 papers in Pathology and Forensic Medicine and 17 papers in Oncology. Recurrent topics in Heribert Juergens's work include Sarcoma Diagnosis and Treatment (37 papers), Lymphoma Diagnosis and Treatment (21 papers) and Cardiac tumors and thrombi (14 papers). Heribert Juergens is often cited by papers focused on Sarcoma Diagnosis and Treatment (37 papers), Lymphoma Diagnosis and Treatment (21 papers) and Cardiac tumors and thrombi (14 papers). Heribert Juergens collaborates with scholars based in Germany, United States and Netherlands. Heribert Juergens's co-authors include Paul A. Meyers, Ian Lewis, Uta Dirksen, Claudia Rössig, Sibylle Pscherer, Bianca Altvater, Silke Landmeier, Andreas Ranft, Georg Gosheger and Sareetha Kailayangiri and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Heribert Juergens

59 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Osteosarcoma treatment – Where do we stand? A state of the art review

2013 1.0k citations Paul A. Meyers, Heribert Juergens et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Heribert Juergens Germany	26	1.6k	1.1k	1.0k	593	531	60	3.3k
Sandra J. Strauss United Kingdom	30	1.5k 0.9×	1.3k 1.2×	844 0.8×	418 0.7×	223 0.4×	94	3.1k
Stefania Benini Italy	32	1.7k 1.1×	864 0.8×	1.4k 1.3×	595 1.0×	218 0.4×	89	3.1k
Alexander J. Chou United States	25	1.1k 0.7×	726 0.7×	931 0.9×	503 0.8×	223 0.4×	61	2.4k
Leo Kager Austria	25	1.2k 0.8×	589 0.5×	926 0.9×	443 0.7×	280 0.5×	100	2.7k
Beate Kempf‐Bielack Germany	14	2.3k 1.4×	1.0k 0.9×	909 0.9×	605 1.0×	187 0.4×	17	3.4k
Mary Louise Keohan United States	34	2.8k 1.8×	2.2k 2.0×	673 0.6×	222 0.4×	769 1.4×	105	4.4k
Roman Kodet Czechia	31	815 0.5×	964 0.9×	1.3k 1.2×	316 0.5×	442 0.8×	171	3.1k
Herlinde Dumez Belgium	35	2.3k 1.5×	1.7k 1.5×	1.5k 1.4×	454 0.8×	150 0.3×	145	4.8k
Antonio López–Pousa Spain	32	1.9k 1.2×	1.7k 1.5×	541 0.5×	273 0.5×	175 0.3×	161	3.4k
Joseph S. Palumbo United States	29	871 0.6×	1.5k 1.3×	820 0.8×	681 1.1×	455 0.9×	100	3.8k

Countries citing papers authored by Heribert Juergens

Since Specialization

Citations

This map shows the geographic impact of Heribert Juergens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heribert Juergens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heribert Juergens more than expected).

Fields of papers citing papers by Heribert Juergens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heribert Juergens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heribert Juergens. The network helps show where Heribert Juergens may publish in the future.

Co-authorship network of co-authors of Heribert Juergens

This figure shows the co-authorship network connecting the top 25 collaborators of Heribert Juergens. A scholar is included among the top collaborators of Heribert Juergens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heribert Juergens. Heribert Juergens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Deventer, Niklas, Georg Gosheger, Tymoteusz Budny, et al.. (2020). Aneurysmal bone cyst inadvertently treated with chemotherapy—A series of three cases. Pediatric Blood & Cancer. 67(10). e28638–e28638. 3 indexed citations

Haveman, Lianne, Andreas Ranft, Henk van den Berg, et al.. (2020). Primary and Metastatic Intracranial Ewing Sarcoma at Diagnosis: Retrospective International Study and Systematic Review. Cancers. 12(6). 1675–1675. 12 indexed citations

Worch, Jennifer, Andreas Ranft, Steven G. DuBois, et al.. (2018). Age dependency of primary tumor sites and metastases in patients with Ewing sarcoma. Pediatric Blood & Cancer. 65(9). e27251–e27251. 32 indexed citations

Foulon, Stéphanie, Bernadette Brennan, Nathalie Gaspar, et al.. (2016). Can postoperative radiotherapy be omitted in localised standard-risk Ewing sarcoma? An observational study of the Euro-E.W.I.N.G group. European Journal of Cancer. 61. 128–136. 55 indexed citations

Krumbholz, Manuela, Tobias Bäuerle, Abbas Agaimy, et al.. (2016). Genomic EWSR1 Fusion Sequence as Highly Sensitive and Dynamic Plasma Tumor Marker in Ewing Sarcoma. Clinical Cancer Research. 22(17). 4356–4365. 61 indexed citations

Andreou, Dimosthenis, Andreas Ranft, Daniel Baumhoer, et al.. (2016). Prognostic factors for local control in Ewing sarcoma (ES) in the Euro-EWING99 trial.. Journal of Clinical Oncology. 34(15_suppl). 11026–11026. 1 indexed citations

Whelan, Jeremy, Marie‐Cécile Le Deley, Uta Dirksen, et al.. (2016). Efficacy of busulfan-melphalan high dose chemotherapy consolidation (BuMel) in localized high-risk Ewing sarcoma (ES): Results of EURO-EWING 99-R2 randomized trial (EE99R2Loc).. Journal of Clinical Oncology. 34(15_suppl). 11000–11000. 7 indexed citations

Benson, Charlotte, Piotr Rutkowski, Jean‐Yves Blay, et al.. (2014). Etoposide and carbo‐or cisplatin combination therapy in refractory or relapsed Ewing sarcoma: A large retrospective study. Pediatric Blood & Cancer. 62(1). 40–44. 22 indexed citations

Ehlert, Karoline, et al.. (2014). Diffuse Hemorrhagic Colitis in a Patient With Dyskeratosis Congenita After Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation. Journal of Pediatric Hematology/Oncology. 37(1). e41–e44. 2 indexed citations

10.

Pappo, Alberto S., Shreyaskumar Patel, John Crowley, et al.. (2011). R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research Through Collaboration Study. Journal of Clinical Oncology. 29(34). 4541–4547. 252 indexed citations

11.

Juergens, Heribert, Najat C. Daw, Birgit Geoerger, et al.. (2011). Preliminary Efficacy of the Anti-Insulin–Like Growth Factor Type 1 Receptor Antibody Figitumumab in Patients With Refractory Ewing Sarcoma. Journal of Clinical Oncology. 29(34). 4534–4540. 165 indexed citations

12.

Koschmieder, Steffen, Mirle Schemionek, Bianca Altvater, et al.. (2011). NK cells are dysfunctional in human chronic myelogenous leukemia before and on imatinib treatment and in BCR–ABL-positive mice. Leukemia. 26(3). 465–474. 48 indexed citations

13.

Vrachimis, Alexis, Uta Dirksen, Johannes Weßling, et al.. (2010). PET-Nachsorge von Patienten mit Ewing-Sarkomen am Körperstamm: Müssen die Unterschenkel berücksichtigt werden?. Nuklearmedizin - NuclearMedicine. 49(5). 183–186. 3 indexed citations

14.

Pfluger, Thomas, Kai Uwe Juergens, Regine Kluge, et al.. (2010). Empfehlungen zur Durchführung der Ganz körper-18F-FDG-PET und -PET/CT bei Kindern mit onkologischen Erkrankungen. Nuklearmedizin - NuclearMedicine. 49(6). 225–233. 5 indexed citations

15.

Altvater, Bianca, Silke Landmeier, Sibylle Pscherer, et al.. (2009). 2B4 (CD244) Signaling by Recombinant Antigen-specific Chimeric Receptors Costimulates Natural Killer Cell Activation to Leukemia and Neuroblastoma Cells. Clinical Cancer Research. 15(15). 4857–4866. 165 indexed citations

16.

Brinkrolf, Peter, Silke Landmeier, Bianca Altvater, et al.. (2009). A high proportion of bone marrow T cells with regulatory phenotype (CD4+CD25^hiFoxP3+) in Ewing sarcoma patients is associated with metastatic disease. International Journal of Cancer. 125(4). 879–886. 46 indexed citations

17.

Landmeier, Silke, Bianca Altvater, Sibylle Pscherer, et al.. (2007). Gene-Engineered Varicella-Zoster Virus–Reactive CD4+ Cytotoxic T Cells Exert Tumor-Specific Effector Function. Cancer Research. 67(17). 8335–8343. 25 indexed citations

18.

Alldinger, Ingo, Uta Dirksen, Andreas Ranft, et al.. (2007). Microsatellite instability in Ewing tumor is not associated with loss of mismatch repair protein expression. Journal of Cancer Research and Clinical Oncology. 133(10). 749–759. 21 indexed citations

19.

Ozaki, Toshifumi, Karl‐Ludwig Schaefer, Daniel Wai, et al.. (2002). Genetic imbalances revealed by comparative genomic hybridization in osteosarcomas. International Journal of Cancer. 102(4). 355–365. 74 indexed citations

20.

Ozaki, Toshifumi, Karl‐Ludwig Schaefer, Daniel Wai, et al.. (2002). Population-based genetic alterations in Ewing’s tumors from Japanese and European Caucasian patients. Annals of Oncology. 13(10). 1656–1664. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact